רמב"ם - הקריה הרפואית לבריאות האדם, הידוע גם בשם "המרכז הרפואי רמב"ם" ובקצרה "רמב"ם", הוא המרכז הרפואי הגדול ביותר בצפונה של ישראל. רמב"ם הוא בית החולים השלישוני היחיד באזור. זהו בית חולים אוניברסיטאי, המקיים קשרים הדוקים עם הפקולטה לרפואה של הטכניון, ומשמש מתקן ההוראה הקלינית העיקרי של הפקולטה.

During the past decade, Rambam Medical Center; Heamatology & Bone Marrow Transplantation conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 7 clinical trials were completed, i.e. on average, 233.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rambam Medical Center; Heamatology & Bone Marrow Transplantation" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "Millennium Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rambam Medical Center; Heamatology & Bone Marrow Transplantation" #1 collaborator was "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator, "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator, "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 1 trials as a collaborator and "Onxeo" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Rambam Medical Center; Heamatology & Bone Marrow Transplantation" are "Multiple Myeloma" (4 trials), "Non-Hodgkin's Lymphoma" (2 trials), "Follicular Lymphoma" (1 trials), "Lymphocytic Leukemia, Chronic" (1 trials) and "Lymphoma, Large B-Cell, Diffuse" (1 trials). Many other conditions were trialed in "Rambam Medical Center; Heamatology & Bone Marrow Transplantation" in a lesser frequency.

Most popular intervention types in "Rambam Medical Center; Heamatology & Bone Marrow Transplantation" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Bortezomib" (2 trials), "Cyclophosphamide" (2 trials), "Daratumumab" (2 trials), "Dexamethasone" (2 trials) and "Prednisone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Rambam Medical Center; Heamatology & Bone Marrow Transplantation" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Rambam Medical Center; Heamatology & Bone Marrow Transplantation". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Rambam Medical Center; Heamatology & Bone Marrow Transplantation, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Rambam Medical Center; Heamatology & Bone Marrow Transplantation, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".